DEUTETRABENAZINE: UPDATE ON FIRST TIME USE OF SD-809 IN HUNTINGTON'S DISEASE (FIRST-HD) AND ALTERNATIVE FOR REDUCING CHOREA IN HUNTINGTON'S DISEASE (ARC-HD)

被引：0
|
作者：
Testa, Claudia [1 ]
机构：
[1] Huntington Study Grp, Rochester, NY USA
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2016年 / 87卷
关键词：
D O I：
10.1136/jnnp-2016-314597.286
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
M1
引用
收藏
页码：A101 / A101
页数：1
相关论文
共 39 条
  • [31] Evolving inclusion criteria in early manifest Huntington's disease (HD) to address striatal atrophy: Lessons from HD-GeneTRX-1, the first gene therapy trial
    Furr-Stimming, E.
    Testa, C.
    Larson, P.
    Ross, C.
    Lonser, R.
    Samii, A.
    Cooper, D.
    Ying, S.
    Clarkin, M.
    Sawyer, E.
    Reilmann, R.
    MOVEMENT DISORDERS, 2021, 36 : S100 - S101
  • [32] Update on the LEGATO-HD Study: A Phase II Study Assessing the Efficacy and Safety of Laquinimod as a Treatment for Huntington's Disease
    Reilmann, Ralf
    Gordon, Mark Forrest
    Anderson, Karen
    Feigin, Andrew
    Tabrizi, Sarah
    Leavitt, Blair
    Stout, Julie
    Piccini, Paola
    Gillespie, Michael
    Rynkowski, Gail
    Swanson, Sarah
    Savola, Juha
    Papapetropoulos, Spyros
    Borowsky, Beth
    Hayden, Michael
    NEUROTHERAPEUTICS, 2018, 15 (01) : 260 - 261
  • [33] Freesurfer Software Update Significantly Impacts Striatal Volumes in the Huntington's Disease Young Adult Study and Will Influence HD-ISS Staging
    Knights, Harry
    Coleman, Annabelle
    Hobbs, Nicola Z.
    Tabrizi, Sarah J.
    Scahill, Rachael I.
    JOURNAL OF HUNTINGTONS DISEASE, 2024, 13 (01) : 77 - 90
  • [34] MODEL-BASED META-ANALYSIS (MBMA) OF TOTAL MOTOR SCORE, CHOREA SCORE, AND TOTAL FUNCTIONAL CAPACITY FOR PATIENTS WITH HUNTINGTON'S DISEASE (HD)
    Jin, Y.
    Ahadieh, S.
    Pickering, E.
    Evans, R.
    Liu, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S37 - S37
  • [35] Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD (Jan, 10.1007/s40120-024-00703-9, 2025)
    Stimming, Erin Furr
    Claassen, Daniel O.
    Sen, Ginny P.
    Klepitskaya, Olga
    Serbin, Michael
    Kim, Hyunwoo
    Hinton, Sean C.
    Haubenberger, Dietrich
    NEUROLOGY AND THERAPY, 2025,
  • [36] Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
    Stimming, Erin Furr
    Claassen, Daniel
    Kayson, Elise
    Goldstein, Jody
    Mehanna, Raja
    Zhang, Hui
    Liang, Grace S.
    Haubenberger, Dietrich
    LANCET NEUROLOGY, 2023, 22 (06): : 494 - 504
  • [37] Use of the Enroll-HD Observational Study as a Platform for Enriching Data Collection in a 12-month Nested Randomized Controlled Feasibility Study of a Physical Activity Intervention in People with Huntington's Disease (PACE-HD)
    Drew, Cheney J.
    Handley, Olivia
    Townhill, Jenny
    Williams-Thomas, Rhys
    Busse, Monica
    Quinn, Lori
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1374 - 1374
  • [38] Ultrasound guided fetal tissue retrieval improves yield of viable neural cells for use in neural transplantation swift-HD (South Wales initiative for transplantation Huntington's disease)
    Precious, SV
    Kelly, CM
    Sims, A
    Penketh, RJ
    Amso, NN
    Dunnett, SB
    Rosser, AE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [39] Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial (vol 22, pg 494, 2023)
    Granit, V
    Benatar, M.
    Kurtoglu, M.
    LANCET NEUROLOGY, 2023, 22 (09): : E10 - E10
1234